PPL Corporation (PPL)

CTI BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	294	306	331	356	3,571	442
Accounts Receivable	1,416	1,446	1,378	1,448	890	904
Other Receivables	122	76	271	150	58	86
Inventory	504	511	505	443	322	302
Prepaid Expenses	192	136	103	92	60	53
Restricted Cash	-	-	-	-	1	1
Other Current Assets	395	405	344	335	105	129
Total Current Assets	2,923	2,880	2,932	2,824	5,007	20,900
Property, Plant & Equipment	34,356	33,149	31,418	30,238	25,470	24,500
Regulatory Assets	2,055	2,060	1,874	1,819	1,236	1,262
Goodwill	2,247	2,247	2,247	2,248	716	716
Other Intangible Assets	312	314	306	313	343	351
Long-Term Deferred Tax Assets	-	12	9	6	12	17
Other Long-Term Assets	470	407	450	389	439	370
Total Assets	42,363	41,069	39,236	37,837	33,223	48,116
Accounts Payable	1,135	1,196	1,104	1,201	679	745
Accrued Expenses	202	221	175	148	112	135
Short-Term Debt	1,286	303	992	985	69	1,168
Current Portion of Long-Term Debt	1,219	551	2	355	475	1,076
Current Portion of Leases	-	24	-	-	-	-
Current Income Taxes Payable	143	103	130	124	96	69
Other Current Liabilities	993	935	937	976	892	11,862
Total Current Liabilities	4,978	3,333	3,340	3,789	2,323	15,055
Long-Term Debt	15,349	16,009	14,674	12,955	10,745	13,702
Long-Term Leases	-	78	-	-	-	-
Pension & Post-Retirement Benefits	601	611	527	393	278	249
Long-Term Deferred Tax Liabilities	5,462	5,366	5,196	5,218	4,861	4,348
Other Long-Term Liabilities	1,687	1,595	1,566	1,564	1,293	1,389
Total Liabilities	28,077	26,992	25,303	23,919	19,500	34,743
Common Stock	8	8	8	8	8	8
Additional Paid-In Capital	12,343	12,346	12,326	12,317	12,303	12,270
Retained Earnings	3,027	2,835	2,710	2,681	2,572	5,315
Treasury Stock	-902	-928	-948	-967	-1,003	-
Comprehensive Income & Other	-190	-184	-163	-124	-157	-4,220
Total Common Equity	14,286	14,077	13,933	13,915	13,723	13,373
Minority Interest	-	-	-	3	-	-
Shareholders' Equity	14,286	14,077	13,933	13,918	13,723	13,373
Total Liabilities & Equity	42,363	41,069	39,236	37,837	33,223	48,116
Total Debt	17,854	16,965	15,668	14,295	11,289	15,946
Net Cash (Debt)	-17,560	-16,659	-15,337	-13,939	-7,718	-15,504
Net Cash Per Share	-23.69	-22.52	-20.78	-18.92	-10.09	-20.15
Filing Date Shares Outstanding	739.52	738.29	737.6	736.68	735.36	768.98
Total Common Shares Outstanding	739.31	738.03	737.13	736.49	735.11	768.91
Working Capital	-2,055	-453	-408	-965	2,684	5,845
Book Value Per Share	19.32	19.07	18.90	18.89	18.67	17.39
Tangible Book Value	11,727	11,516	11,380	11,354	12,664	12,306
Tangible Book Value Per Share	15.86	15.60	15.44	15.42	17.23	16.00
Machinery	41,171	40,391	38,608	36,961	30,477	29,040
Construction In Progress	3,088	2,390	1,917	1,583	1,256	1,268

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.

SEC Filings: 10-K · 10-Q